1992
DOI: 10.1016/s0006-8993(10)80047-2
|View full text |Cite
|
Sign up to set email alerts
|

Identification of an AII(3–8) [AIV] binding site in guinea pig hippocampus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
69
0
1

Year Published

1998
1998
2017
2017

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 147 publications
(76 citation statements)
references
References 14 publications
6
69
0
1
Order By: Relevance
“…Of most importance, the acute application of one of these analogs, Nle 1 -AngIV, reverses deficits in dementia models induced by 1) treatment with the cholinergic muscarinic receptor antagonist scopolamine (Pederson et al, 2001), 2) kainic acid injections into the hippocampus (Stubley-Weatherly et al, 1996), 3) perforant path cuts (Wright et al, 1999), and 4) ischemia resulting from transient four-vessel occlusion . Consistent with these behavioral and electrophysiological results, brain binding sites for 125 I-AngIV have been autoradiographically localized in structures known to mediate cognitive processing including the neocortex, hippocampus, and basal nucleus of Meynert (Harding et al, 1992;Chai et al, 2000;Wright and Harding, 2008). It should be noted that the AT 1 angiotensin receptor subtype may also contribute to the cognitive effects of AngIV (De Bundel et al, 2010).…”
Section: Introductionsupporting
confidence: 65%
“…Of most importance, the acute application of one of these analogs, Nle 1 -AngIV, reverses deficits in dementia models induced by 1) treatment with the cholinergic muscarinic receptor antagonist scopolamine (Pederson et al, 2001), 2) kainic acid injections into the hippocampus (Stubley-Weatherly et al, 1996), 3) perforant path cuts (Wright et al, 1999), and 4) ischemia resulting from transient four-vessel occlusion . Consistent with these behavioral and electrophysiological results, brain binding sites for 125 I-AngIV have been autoradiographically localized in structures known to mediate cognitive processing including the neocortex, hippocampus, and basal nucleus of Meynert (Harding et al, 1992;Chai et al, 2000;Wright and Harding, 2008). It should be noted that the AT 1 angiotensin receptor subtype may also contribute to the cognitive effects of AngIV (De Bundel et al, 2010).…”
Section: Introductionsupporting
confidence: 65%
“…[8][9][10][11][12] The distribution between species is consistent with high levels of radioligand binding observed in the motor nuclei and in areas associated with cognitive and sensorimotor functions, such as the hippocampus, neocortex and cerebellum. Of particular interest is the occurrence of high affinity binding in areas associated with memory; areas of basal forebrain cholinergic nuclei, including the medial septal complex and the basal nucleus of Meynert, and their terminal fields, such as the hippocampus and neocortex.…”
Section: Angiotensin IVsupporting
confidence: 59%
“…56,57 This binding site shows high selectivity for Ang IV followed by Ang III (10-fold lower affinity) ӷ Ang II, [Sar 1 Ile 8 ] Ang II ӷ losartan, PD 123177 and CGP 42112A. [58][59][60][61][62] The AT 4 receptor also displays a distinct distribution pattern, being found in the cholinergic areas and motor and sensory regions in the brain. 59,63 It is also found in the heart, 60 adrenal cortex, 57,64 vascular smooth muscle cells, 61 and numerous other tissues.…”
Section: Ang IVmentioning
confidence: 99%